PEPFAR News and Research

RSS

TB preventive treatment delivers real-world gains for people with HIV

Tuberculosis (TB) is responsible for about a quarter of all AIDS deaths. In 2024, it was also the leading cause of death among people with HIV. This is despite TB being a preventable and curable disease.

17 Aug 2026

Research says global HIV efforts need renewed funding and focus

As the world marks World AIDS Day on Dec. 1, world-renowned infectious disease expert Anthony Fauci, MD, and his colleague Greg Folkers, MS, MPH, highlight advances made in the treatment and prevention of HIV that could finally end the pandemic, but caution, "History will judge us harshly should we squander this opportunity."

1 Dec 2025

US funding cuts threaten decades of progress in pediatric tuberculosis

A new study projects that US funding cuts to global health aid will have a catastrophic effect on pediatric TB, with children in Sub-Saharan Africa and Southeast Asia likely to experience a significant spike in preventable cases and deaths over the next decade-even by the most conservative estimates-unless funding is restored.

21 Oct 2025

Funding cuts threaten decades of progress in the fight against HIV

Countries worldwide must step up to support the fight against HIV or face the “ticking time bomb” left by the wholesale withdrawal of US funding, warns UNAIDS.

22 Jul 2025

KFF Health News' 'What the Health?': The Senate saves PEPFAR funding — for now

The Senate has passed — and sent back to the House — a bill that would allow the Trump administration to claw back some $9 billion in previously approved funding for foreign aid and public broadcasting.

17 Jul 2025

US withdrawal from global health bodies threatens millions with hunger and disease

A new Perspective in The American Journal of Clinical Nutrition warns of catastrophic global nutrition and health impacts if the US withdraws from the WHO and dismantles USAID. The authors urge urgent policy reversal and call for collaborative global action to prevent widespread humanitarian crises.

19 May 2025

Long-acting HIV drug emerges from decades of research and advocacy

In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be especially powerful.

8 May 2025

Call for urgent support as US funding cuts threaten HIV/AIDS programs

In the face of ongoing funding disruptions to US foreign assistance programmes, a group of international experts calls for urgent action to ensure the continuation of life-saving interventions and support for children and families affected by HIV/AIDS in sub-Saharan Africa.

9 Apr 2025

Experts warn of rising HIV deaths with planned aid cuts

Global deaths from HIV/AIDS and new infections could soar to levels unseen since the start of the century if planned funding cuts to foreign aid are sustained, undermining years of progress, experts warn.

8 Apr 2025

US funding suspension threatens health and research programs in Uganda

Malaria vaccination and HIV treatment are among numerous health programmes at risk in Uganda as the country's science research centres suffer the impact of a US freeze on overseas aid.

12 Feb 2025

US aid freeze puts HIV treatment in Africa at risk

Milicent Muyoma has been turned away twice from the clinic where she collects her HIV medication in Mathare, an informal settlement in Nairobi, Kenya.

6 Feb 2025

WHO voices concern over HIV program funding pause

The World Health Organization (WHO) expresses deep concern on the implications of the immediate funding pause for HIV programmes in low- and middle-income countries.

29 Jan 2025

IHME study reveals significant progress and gaps in the global fight against HIV/AIDS

The Institute for Health Metrics and Evaluation (IHME) has published a new study in The Lancet HIV journal that revealed significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate the world is not on track to meet the ambitious UNAIDS 2030 targets.

25 Nov 2024

Georgetown University receives $27.5 million grant to combat HIV/AIDS in Haiti

The U.S. Centers for Disease Control and Prevention (CDC) and the President's Emergency Plan for AIDS Relief (PEPFAR), have awarded $27.5 million to the Center for Global Health Practice and Impact (CGHPI) at Georgetown University Medical Center to expand its ongoing work in Haiti to address HIV/AIDS.

17 Oct 2024

PrEPVacc HIV vaccine trial shows no reduction in infections

The results of the PrEPVacc HIV vaccine trial conducted in Eastern and Southern Africa, which ran between 2020 and 2024, show conclusively that neither of the two experimental vaccine regimens tested reduced HIV infections among the study population.

23 Jul 2024

Major global commitments announced to eradicate cervical cancer

Governments, donors, multilateral institutions, and partners today announced major new policy, programmatic and financial commitments, including nearly US$ 600 million in new funding, to eliminate cervical cancer.

28 Mar 2024

Closing the gender gap in HIV treatment could slash infection rates in Uganda

A study looking at 15 years of HIV transmission and suppression in Uganda reveals how closing gender gaps in treatment could slash infection rates.

8 Dec 2023

New early phase study evaluates “on-demand” HIV prevention method for women

A fast-dissolving vaginal insert that women would use at or around the time of sex as an "on-demand" HIV prevention method is being evaluated in a new early phase study being conducted by MATRIX, a United States Agency for International Development (USAID)-funded project focused on the early research and development of innovative HIV prevention products for women.

7 Dec 2023

Do Republican spending cuts threaten federal HIV funding? For some programs, yes.

Republicans in Congress are "trying to wipe out federal funding to end the HIV epidemic."

14 Nov 2023

Study launched to test a vaginal film that slowly dissolves over the course of 30 days

A vaginal film designed to slowly dissolve over the course of 30 days is being put to the test for the first time in a study launched this week that aims to determine its feasibility and acceptability as a potential HIV prevention method for women.

2 Nov 2023